200
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Sexual function through decades: association with androgens and cardiometabolic features

ORCID Icon, ORCID Icon & ORCID Icon
Pages 489-495 | Received 19 Dec 2019, Accepted 11 Mar 2020, Published online: 15 Apr 2020

References

  • Can G. Kanserde Cinsel Sağlık. Türk Androloji Bülteni 2004;355–6
  • Basson RB, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000;163:888–93
  • Berman JA, Adhikari SP, Goldstein I. Anatomy and physiology of female sexual function and dysfunction: classification, evaluation and treatment options. Eur Urol 2000;38:20–9
  • Addis IB, Van Den Eeden SK, Wassel-Fyr CL, et al. Sexual activity and function in middle-aged and older women. Obstet Gynecol 2006;107:755–64
  • Dennerstein L, Lehert P, Burger H, Guthrie J. Sexuality. Am J Med 2005;118:59–63
  • Gracia CR, Freeman EW, Sammel MD, Lin H, Mogul M. Hormones and sexuality during transition to menopause. Obstet Gynecol 2007;109:831–40
  • Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985;47:339–51
  • Kaplan HS, Owett T. The female androgen deficiency syndrome. J Sex Marital Ther 1993;19:3–24
  • Oddens BJ. New insight into the functions of ‘male hormones’ in women. Newsletter of the International Health Foundation 1996;3:14–19
  • Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537–44
  • Guay A, Munarriz R, Jacobson J, et al. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: part A. Serum androgen levels in women aged 20–49 years with no complaints of sexual dysfunction. Int J Impot Res 2004;16:112–20
  • Overlie I, Moen MH, Morkrid L, SkJÆraasen JS, Holte A. The endocrine transition around menopause – a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstet Gynecol Scand 1999;78:642–7
  • Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847–53
  • Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 2008;61:67–77
  • Yoldemir T, Erenus M. The prevalence of metabolic syndrome in pre- and post-menopausal women attending a tertiary clinic in Turkey. Eur J Obstet Gynecol Reprod Biol 2012;164:172–5
  • Yoldemir T, Garibova N, Atasayan K. The association between sexual dysfunction and metabolic syndrome among Turkish postmenopausal women. Climacteric 2019;22:472–7
  • Yoldemir T, Erenus M, Durmusoglu F. The impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopause. Gynecol Endocrinol 2012;28:884–8
  • Gallagher D, Heymsfield SB, Heo M, et al. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 2000;72:694–701
  • Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1–20
  • Oksuz E, Malhan S. Reliability and validity of the female sexual function index in Turkish population. Sendrom 2005;17:54
  • Yoldemir T, Yavuz DG. The association of osteopenia with levels of serum 25-hydroxyvitamin D and HOMA-IR values. Climacteric 2014;17:268–72
  • Atasayan K, Yoldemir T, Ramoglu S, Yavuz DG. The evaluation of endothelial function and structure in hirsute patients in reproductive age. Eur J Obstet Gynecol Reprod Biol 2016;206:208–12
  • Castelo BC, Blumel JE, Araya H, et al. Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy. J Obstet Gynaecol 2003;23:426–30
  • Hisasue S, Kumamoto Y, Sato Y, et al. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: a Japanese female cohort study. Urology 2005;65:143–8
  • Singh JC, Tharyan P, Kekre NS, Singh G, Gopalakrishnan G. Prevalence and risk factors for female sexual dysfunction in women attending a medical clinic in south India. J Postgrad Med 2009;55:113–20
  • Peeyananjarassri K, Liabsuetrakul T, Soonthornpun K, Choobun T, Manopsilp P. Sexual functioning in postmenopausal women not taking hormone therapy in the Gynecological and Menopause Clinic, Songklanagarind Hospital measured by Female Sexual Function Index questionnaire. J Med Assoc Thai 2008;91:625–32
  • Blumel JE, Bravo F, Recavarren M, Sarra S. [Sexual function in postmenopausal women using hormone replacement therapy]. Rev Med Chil 2003;131:1251–5
  • Lewis RW, Fugl-Meyer KS, Bosch R, et al. Epidemiology/Risk Factors of Sexual Dysfuntion. J Sex Med 2004;1:35–9
  • Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E. The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish woman. Urol Int 2004;72:52–7
  • Aslan E, Beji NK, Gungor I, Kadioglu A, Dikencik BK. Prevalence and risk factors for low sexual function in women: a study of 1,009 women in an outpatient clinic of a university hospital in Istanbul. J Sex Med 2008;5:2044–52
  • Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008;112:970–8
  • Kömürcü N, İşbilen A. Adaptation of women to sexual life during the postmenopausal period. Turk J Urol 2011;37:326–30
  • Dennerstein L, Alexander JL, Kotz K. The menopause and sexual functioning: a review of the population-based studies. Annu Rev Sex Res 2003;14:64–82
  • Avis NE, Zhao X, Johannes CB, et al. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women’s Health Across the Nation (SWAN). Menopause 2005;12:385–98
  • Avis NE, Brockwell S, Randolph JF, Jr, et al. Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women’s Health Across the Nation. Menopause 2009;16:442–52
  • Thomas HN, Thurston RC. A biopsychosocial approach to women’s sexual function and dysfunction at midlife: a narrative review. Maturitas 2016;87:49–60
  • Hayes R, Dennerstein L. The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies. J Sex Med 2005;2:317–30
  • Avis NE, Stellato R, Crawford S, et al. Is there an association between menopause status and sexual functioning? Menopause 2000;7:297–309
  • Maseroli E, Scavello I, Vignozzi L. Cardiometabolic risk and female sexuality—part I. risk factors and potential pathophysiological underpinnings for female vasculogenic sexual dysfunction syndromes. Sex Med Rev 2018;6:508–24
  • Modelska K, Cummings S. Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials. Am J Obstet Gynecol 2003;188:286–93
  • Camacho ME, Reyes-Ortiz CA. Sexual dysfunction in the elderly: age or disease? Int J Impot Res 2005;17:S52–56
  • Esposito K, Ciotola M, Maiorino MI, et al. Hyperlipidemia and sexual function in premenopausal women. J Sex Med 2009;6:1696–703
  • Alvisi S, Baldassarre M, Lambertini M, et al. Sexuality and psychopathological aspects in premenopausal women with metabolic syndrome. J Sex Med 2014;11:2020–8
  • Esposito K, Maiorino M, Bellastella G, et al. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res 2010;22:179–84
  • Veronelli A, Mauri C, Zecchini B, et al. Sexual dysfunction is frequent in premenopausal women with diabetes, obesity, and hypothyroidism, and correlates with markers of increased cardiovascular risk. A preliminary report. J Sex Med 2009;6:1561–8
  • Baldassarre M, Alvisi S, Mancini I, et al. Impaired lipid profile is a risk factor for the development of sexual dysfunction in women. J Sex Med 2016;13:46–54
  • Maseroli E, Fanni E, Cipriani S, et al. Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance. J Sex Med 2016;13:1651–61
  • Duncan LE, Lewis C, Jenkins P, et al. Does hypertension and its pharmacotherapy affect the quality of sexual function in women? Am J Hypertens 2000;13:640–7
  • Burchardt M, Burchardt T, Anastasiadis AG, et al. Sexual dysfunction is common and overlooked in female patients with hypertension. J Sex Marital Ther 2002;28:17–26
  • Leiblum SR, Baume RM, Croog SH. The sexual functioning of elderly hypertensive women. J Sex Marital Ther 1994;20:259–70
  • Doumas M, Tsiodras S, Tsakiris A, et al. Female sexual dysfunction in essential hypertension: a common problem being uncovered. J Hypertens 2006;24:2387–92
  • Kütmeç C, Yurtsever S. Effects of sexual function of essential hypertensions in women. Eur J Cardiovasc Nurs 2011;10:56–63
  • Spatz ES, Canavan ME, Desai MM, et al. Sexual activity and function among middle-aged and older men and women with hypertension. J Hypertens 2013;31:1096–105
  • Foy CG, Newman JC, Berlowitz DR, et al. SPRINT Study Research Group. Blood pressure, sexual activity, and dysfunction in women with hypertension: baseline findings from the Systolic Blood Pressure Intervention Trial (SPRINT). J Sex Med 2016;13:1333–46
  • Pontiroli AE, Cortelazzi D, Morabito A. Female sexual dysfunction and diabetes: a systematic review and meta-analysis. J Sex Med 2013;10:1044–51
  • Park K, Ahn K, Chang JS, Lee SE, Ryu SB, Park YI. Diabetes induced alteration of clitoral hemodynamics and structure in the rabbit. J Urol 2002;168:1269–72
  • Greenblatt RB. Hormone factors in libido. J Clin Endocrinol Metab 1942;3;305.
  • Traish AM, Botchevar E, Kim NN. Biochemical factors modulating female genital sexual arousal physiology. J Sex Med 2010;7:2925–46
  • Bancroft J. Sex and aging. N Engl J Med 2007;357:820–2
  • Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91–6
  • Turna B, Apaydin E, Semerci B, Altay B, Cikili N, Nazli O. Women with low libido: correlation of decreased androgen levels with female sexual function index. Int J Impot Res 2005;17:148–53
  • Çoşar E, Erenus M. Hormones and sexual functioning in menopousal transition. Marmara Med J 2007;20:150–3
  • Elraiyah T, Sonbol MB, Wang Z, et al. Clinical review: the benefits and harms of systemic testosterone therapy in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab 2014;99:3543–50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.